412 related articles for article (PubMed ID: 29122155)
1. Rituximab Hypersensitivity: Evaluation, Desensitization, and Potential Mechanisms.
Wong JT; Long A
J Allergy Clin Immunol Pract; 2017; 5(6):1564-1571. PubMed ID: 29122155
[TBL] [Abstract][Full Text] [Related]
2. Oxaliplatin hypersensitivity: evaluation, implications of skin testing, and desensitization.
Wong JT; Ling M; Patil S; Banerji A; Long A
J Allergy Clin Immunol Pract; 2014; 2(1):40-5. PubMed ID: 24565767
[TBL] [Abstract][Full Text] [Related]
3. Desensitization to rituximab in a multidisciplinary setting.
Amorós-Reboredo P; Sánchez-López J; Bastida-Fernández C; do Pazo-Oubiña F; Borràs-Maixenchs N; Giné E; Valero A; Creus-Baró N
Int J Clin Pharm; 2015 Oct; 37(5):744-8. PubMed ID: 25999014
[TBL] [Abstract][Full Text] [Related]
4. Carboplatin hypersensitivity: a 6-h 12-step protocol effective in 35 desensitizations in patients with gynecological malignancies and mast cell/IgE-mediated reactions.
Lee CW; Matulonis UA; Castells MC
Gynecol Oncol; 2004 Nov; 95(2):370-6. PubMed ID: 15491759
[TBL] [Abstract][Full Text] [Related]
5. Rituximab desensitization in three patients with severe rituximab allergy.
Öztürk E; Özyiğit LP; Öztürk AB; Akay MO; Çetiner M; Ferhanoğlu B
Curr Probl Cancer; 2017; 41(5):349-354. PubMed ID: 28860080
[TBL] [Abstract][Full Text] [Related]
6. Hypersensitivity reactions to mAbs: 105 desensitizations in 23 patients, from evaluation to treatment.
Brennan PJ; Rodriguez Bouza T; Hsu FI; Sloane DE; Castells MC
J Allergy Clin Immunol; 2009 Dec; 124(6):1259-66. PubMed ID: 19910036
[TBL] [Abstract][Full Text] [Related]
7. Hypersensitivity and desensitization to antineoplastic agents: outcomes of 189 procedures with a new short protocol and novel diagnostic tools assessment.
Madrigal-Burgaleta R; Berges-Gimeno MP; Angel-Pereira D; Ferreiro-Monteagudo R; Guillen-Ponce C; Pueyo C; Gomez de Salazar E; Alvarez-Cuesta E
Allergy; 2013 Jul; 68(7):853-61. PubMed ID: 23647576
[TBL] [Abstract][Full Text] [Related]
8. Rapid desensitization of hypersensitivity reactions to chemotherapy agents.
Castells M
Curr Drug Saf; 2006 Aug; 1(3):243-51. PubMed ID: 18690934
[TBL] [Abstract][Full Text] [Related]
9. Drug Hypersensitivity and Desensitizations: Mechanisms and New Approaches.
de Las Vecillas Sánchez L; Alenazy LA; Garcia-Neuer M; Castells MC
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28632196
[TBL] [Abstract][Full Text] [Related]
10. Desensitization for hypersensitivity reactions to medications.
del Carmen Sancho M; Breslow R; Sloane D; Castells M
Chem Immunol Allergy; 2012; 97():217-33. PubMed ID: 22613865
[TBL] [Abstract][Full Text] [Related]
11. Desensitization protocol for rituximab-induced serum sickness.
Fajt ML; Petrov AA
Curr Drug Saf; 2014; 9(3):240-2. PubMed ID: 24861993
[TBL] [Abstract][Full Text] [Related]
12. Delving into cornerstones of hypersensitivity to antineoplastic and biological agents: value of diagnostic tools prior to desensitization.
Alvarez-Cuesta E; Madrigal-Burgaleta R; Angel-Pereira D; Ureña-Tavera A; Zamora-Verduga M; Lopez-Gonzalez P; Berges-Gimeno MP
Allergy; 2015 Jul; 70(7):784-94. PubMed ID: 25832325
[TBL] [Abstract][Full Text] [Related]
13. Risk-stratification protocol for carboplatin and oxaliplatin hypersensitivity: repeat skin testing to identify drug allergy.
Wang AL; Patil SU; Long AA; Banerji A
Ann Allergy Asthma Immunol; 2015 Nov; 115(5):422-8. PubMed ID: 26298407
[TBL] [Abstract][Full Text] [Related]
14. [Castleman's disease: Rapid desensitization for hypersensitivity reaction to rituximab].
Boin C; Lambert S; Thomann P; Aujoulat O; Kieffer P
Rev Med Interne; 2016 Jun; 37(6):433-6. PubMed ID: 26415921
[TBL] [Abstract][Full Text] [Related]
15. Desensitization in patients with beta-lactam drug allergy.
Yusin JS; Klaustermeyer W; Simmons CW; Baum M
Allergol Immunopathol (Madr); 2013; 41(5):298-303. PubMed ID: 23177979
[TBL] [Abstract][Full Text] [Related]
16. Hypersensitivity reactions to chemotherapy: outcomes and safety of rapid desensitization in 413 cases.
Castells MC; Tennant NM; Sloane DE; Hsu FI; Barrett NA; Hong DI; Laidlaw TM; Legere HJ; Nallamshetty SN; Palis RI; Rao JJ; Berlin ST; Campos SM; Matulonis UA
J Allergy Clin Immunol; 2008 Sep; 122(3):574-80. PubMed ID: 18502492
[TBL] [Abstract][Full Text] [Related]
17. Hypersensitivity reactions to rituximab: 53 successful desensitizations in 7 patients with severe, near-fatal reactions.
Lebel E; Ben-Yehuda D; Bohbot E; Dranitzki Z; Shalit M; Tal Y
J Allergy Clin Immunol Pract; 2016; 4(5):1000-2. PubMed ID: 27329468
[No Abstract] [Full Text] [Related]
18. Outcome of 490 Desensitizations to Chemotherapy Drugs with a Rapid One-Solution Protocol.
Pérez-Rodríguez E; Martínez-Tadeo JA; Pérez-Rodríguez N; Hernández-Santana G; Callero-Viera A; Rodríguez-Plata E; García-Robaina JC
J Allergy Clin Immunol Pract; 2018; 6(5):1621-1627.e6. PubMed ID: 29361511
[TBL] [Abstract][Full Text] [Related]
19. Hypersensitivity and immunologic reactions to biologics: opportunities for the allergist.
Khan DA
Ann Allergy Asthma Immunol; 2016 Aug; 117(2):115-20. PubMed ID: 27499538
[TBL] [Abstract][Full Text] [Related]
20. Risk stratification for desensitization of patients with carboplatin hypersensitivity: clinical presentation and management.
Hesterberg PE; Banerji A; Oren E; Penson RT; Krasner CN; Seiden MV; Wong JT
J Allergy Clin Immunol; 2009 Jun; 123(6):1262-7.e1. PubMed ID: 19501233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
